| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis
|
Truong, Tony H.
|
|
2019
|
25 |
6 |
p. 1172-1178
|
artikel
|
| 2 |
ASTCT Notes
|
|
|
2019
|
25 |
6 |
p. 1269
|
artikel
|
| 3 |
Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades
|
Kilari, Deepak
|
|
2019
|
25 |
6 |
p. 1099-1106
|
artikel
|
| 4 |
Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1–Associated Adult T Cell Lymphoma–Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center
|
Adrianzen Herrera, Diego
|
|
2019
|
25 |
6 |
p. e199-e203
|
artikel
|
| 5 |
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma
|
Singer, Sara
|
|
2019
|
25 |
6 |
p. 1107-1115
|
artikel
|
| 6 |
Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects?
|
Wang, Jie
|
|
2019
|
25 |
6 |
p. e187-e188
|
artikel
|
| 7 |
Clinical and Economic Impact of Cytomegalovirus Infection among Children Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Rastogi, Sonal
|
|
2019
|
25 |
6 |
p. 1253-1259
|
artikel
|
| 8 |
Comments Regarding “ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells”
|
Brown, Anne Rain T.
|
|
2019
|
25 |
6 |
p. e209-e210
|
artikel
|
| 9 |
Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies
|
Ma, Rui
|
|
2019
|
25 |
6 |
p. 1210-1217
|
artikel
|
| 10 |
Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation
|
Gagelmann, Nico
|
|
2019
|
25 |
6 |
p. e204-e208
|
artikel
|
| 11 |
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
|
McCurdy, Shannon R.
|
|
2019
|
25 |
6 |
p. 1128-1135
|
artikel
|
| 12 |
Development of Pre-Engraftment Syndrome, but Not Acute Graft-versus-Host Disease, Reduces Relapse Rate of Acute Myelogenous Leukemia after Single Cord Blood Transplantation
|
Isobe, Masamichi
|
|
2019
|
25 |
6 |
p. 1187-1196
|
artikel
|
| 13 |
Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation
|
Bekker, Vincent
|
|
2019
|
25 |
6 |
p. 1164-1171
|
artikel
|
| 14 |
Editorial Board
|
|
|
2019
|
25 |
6 |
p. A8
|
artikel
|
| 15 |
Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
|
Törlén, Johan
|
|
2019
|
25 |
6 |
p. 1260-1268
|
artikel
|
| 16 |
Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
|
Yuda, Sayako
|
|
2019
|
25 |
6 |
p. 1152-1157
|
artikel
|
| 17 |
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes
|
Hassan, Mojibade
|
|
2019
|
25 |
6 |
p. 1075-1084
|
artikel
|
| 18 |
Fludarabine/Melphalan 100 mg/m2 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis
|
Park, Han-Seung
|
|
2019
|
25 |
6 |
p. 1116-1121
|
artikel
|
| 19 |
Glucagon-Like Peptide-1 Is a Marker of Systemic Inflammation in Patients Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation
|
Ebbesen, Maria Schou
|
|
2019
|
25 |
6 |
p. 1085-1091
|
artikel
|
| 20 |
Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative
|
de la Fuente, Josu
|
|
2019
|
25 |
6 |
p. 1197-1209
|
artikel
|
| 21 |
Have We Achieved a Goldilocks Grade of Graft-Versus-Host Disease?
|
Vasu, Sumithira
|
|
2019
|
25 |
6 |
p. e189-e190
|
artikel
|
| 22 |
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation
|
Scordo, Michael
|
|
2019
|
25 |
6 |
p. 1136-1141
|
artikel
|
| 23 |
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
|
Tamari, Roni
|
|
2019
|
25 |
6 |
p. 1142-1151
|
artikel
|
| 24 |
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation
|
Nawas, Mariam T.
|
|
2019
|
25 |
6 |
p. 1218-1224
|
artikel
|
| 25 |
Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease
|
Stohs, Erica
|
|
2019
|
25 |
6 |
p. 1247-1252
|
artikel
|
| 26 |
Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse
|
Ueda, Masumi
|
|
2019
|
25 |
6 |
p. 1122-1127
|
artikel
|
| 27 |
Masthead (Purpose and Scope)
|
|
|
2019
|
25 |
6 |
p. A7
|
artikel
|
| 28 |
Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability
|
Michelis, Fotios V.
|
|
2019
|
25 |
6 |
p. 1158-1163
|
artikel
|
| 29 |
New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications
|
Engelhardt, Brian G.
|
|
2019
|
25 |
6 |
p. 1225-1231
|
artikel
|
| 30 |
Nonmyeloablative Matched Sibling Donor Hematopoietic Cell Transplantation in Children and Adolescents with Sickle Cell Disease
|
Guilcher, Gregory M.T.
|
|
2019
|
25 |
6 |
p. 1179-1186
|
artikel
|
| 31 |
Officers and Directors of ASBMT
|
|
|
2019
|
25 |
6 |
p. A10
|
artikel
|
| 32 |
Pharmacological Considerations in Antithymocyte Globulin Exposure Calculation
|
Admiraal, Rick
|
|
2019
|
25 |
6 |
p. e213-e215
|
artikel
|
| 33 |
Reply
|
Lee, Daniel W.
|
|
2019
|
25 |
6 |
p. e211-e212
|
artikel
|
| 34 |
Reply to: Pharmacologic Considerations in Antithymocyte Globulin Exposure Calculation
|
Jamani, Kareem
|
|
2019
|
25 |
6 |
p. e216-e217
|
artikel
|
| 35 |
Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma
|
Wang, Jiasheng
|
|
2019
|
25 |
6 |
p. 1092-1098
|
artikel
|
| 36 |
Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report
|
Mohammed, Jaleel
|
|
2019
|
25 |
6 |
p. e191-e198
|
artikel
|
| 37 |
Salivary Changes before and after Hematopoietic Stem Cell Transplantation: A Systematic Review
|
van Leeuwen, Stephanie J.M.
|
|
2019
|
25 |
6 |
p. 1055-1061
|
artikel
|
| 38 |
Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health
|
Morken, Colleen M.
|
|
2019
|
25 |
6 |
p. 1240-1246
|
artikel
|
| 39 |
Table of Contents
|
|
|
2019
|
25 |
6 |
p. A13-A18
|
artikel
|
| 40 |
The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models
|
Fowler, Kenneth A.
|
|
2019
|
25 |
6 |
p. 1062-1074
|
artikel
|
| 41 |
Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant
|
Higgins, Alexandra
|
|
2019
|
25 |
6 |
p. 1232-1239
|
artikel
|
Tijdschrift beschrijving